Prehab for Pancreatic Cancer Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Massachusetts, Worcester

About this trial

The goal of this clinical study is to test whether a structured prehabilitation program can be successfully used by adults with pancreatic cancer who are receiving chemotherapy before planned surgery. Prehabilitation is a program designed to improve a person's physical fitness, nutrition, and symptom control before surgery.

The study's main hypothesis is that patients with pancreatic cancer can take part in and adhere to a multimodal prehabilitation program during chemotherapy, and that doing so may improve physical function, patient experience, and early recovery after surgery.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagnosis of pancreatic ductal adenocarcinoma (PDAC)

Planned neoadjuvant chemotherapy prior to planned surgical resection

Medically stable and cleared to participate in physical activity/exercise programming

Disqualifiers

Age <18 years

Pregnant

Prisoner

Severe cognitive impairment that precludes informed consent or participation

Trial design

Treatments tested in this trial

  • Multimodal Prehabilitation

Treatment groups

20 Participants
are divided into 1 treatment group

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

UMass Memorial Medical CenterRecruiting01655, Worester, MassachusettsUnited StatesUnited States

Sponsors and collaborators

University of Massachusetts, Worcester

Lead sponsor

Pancreatic Cancer Alliance

Collaborator